New obesity drug AMG 513 enters first human tests
NCT ID NCT06585462
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial is testing a new drug called AMG 513 in 80 adults with obesity. The main goal is to see if the drug is safe and how the body handles it. Participants will receive either the drug or a placebo by injection, and researchers will monitor for side effects and measure drug levels in the blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AMG 513
What this could lead to
If successful, this could lead to a new treatment option for obesity, helping people manage their weight.
What could go wrong
This is a very early Phase 1 trial with only 80 people, so it is primarily checking safety. The drug may not work for weight loss or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Anaheim Clinical Trials
RECRUITINGAnaheim, California, 92801, United States
-
Clinical Neuroscience Solutions - Jacksonville
RECRUITINGJacksonville, Florida, 32256, United States
-
Clinical Pharmacology of Miami, LLC
RECRUITINGMiami, Florida, 33172, United States
-
Fomat Medical Research
RECRUITINGOxnard, California, 93030, United States
-
Lillestol Research LLC
RECRUITINGFargo, North Dakota, 58104, United States
-
New Horizon Research Center
RECRUITINGMiami, Florida, 33165, United States
-
Orange County Research Center
RECRUITINGLake Forest, California, 92630, United States
-
Pinnacle Clinical Research
RECRUITINGAustin, Texas, 78757, United States
-
Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group
RECRUITINGUnion City, Georgia, 30291, United States
-
Translational Clinical Research LLC
RECRUITINGAventura, Florida, 33180, United States